Paclitaxel Polymeric Micelles (Shanghai Yizhong Pharmaceutical)

紫杉醇聚合物胶束 (上海谊众药业股份有限公司)

Report date: 2025/07/17 10:59:49

Base Information

Drug NamePaclitaxel Polymeric Micelles (Shanghai Yizhong Pharmaceutical)
Drug Alias Name紫杉醇胶束紫晟
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitorsMicrotubule inhibitors
TargetsTubulin
Therapy Area/IndicationsMetastatic breast cancerCarcinoma, Non-Small-Cell LungLung Neoplasms +[8] 
Global Approved IndicationsCarcinoma, Non-Small-Cell Lung
Approved Indications in ChinaCarcinoma, Non-Small-Cell Lung
Original Approved Country/TerritoryMainland China
Original Approved Date2021/10/26
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Yizhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTongji Hospital Tongji Of Huazhong University Of Science & Technology, ChinaShanghai Yizhong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerCarcinoma, Non-Small-Cell LungLung Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A